Skip to main content
. 2020 Oct 19;4(20):5040–5049. doi: 10.1182/bloodadvances.2020002305

Table 2.

Adverse events

Adverse event Total, n Grades 1-2, n Grades 3-4, n
Hematological 52 6 46
Infective 50 25 25
Hepatic 33 25 8
Metabolic abnormalities 29 24 5
Other 28 25 3
Gastrointestinal 23 22 1
Cardiac 15 9 6
Bleeding 6 4 2
Skin 6 6 0
Urinary 5 2 3

Data are the number of events recorded in the entire population.